Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Clinical trial NCT06632912 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06632912
Sponsor: National Vaccine and Serum Institute, China
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papillomavirus (HPV) Infection HPV (Human Papillomavirus)-Associated Carcinoma

Start date: 2025-11-21
Primary completion: 2032-07-01
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.